tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MLYS Stock Latest News

Mineralys Therapeutics Highlights Positive Earnings Call
Company AnnouncementsMineralys Therapeutics Highlights Positive Earnings Call
9d ago
MLYS
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
PremiumRatings
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
9d ago
MLYS
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
PremiumCompany Announcements
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
10d ago
MLYS
Promising Growth Ahead: Mineralys Therapeutics Positioned for Success with Robust Financials and Key Hypertension Study Results
PremiumRatings
Promising Growth Ahead: Mineralys Therapeutics Positioned for Success with Robust Financials and Key Hypertension Study Results
10d ago
MLYS
Mineralys Therapeutics reports Q4 EPS (98c), consensus ($1.08)
PremiumThe Fly
Mineralys Therapeutics reports Q4 EPS (98c), consensus ($1.08)
10d ago
MLYS
Mineralys Therapeutics sees cash runway through 1Q26
PremiumThe FlyMineralys Therapeutics sees cash runway through 1Q26
10d ago
MLYS
Is MLYS a Buy, Before Earnings?
Premium
Pre-Earnings
Is MLYS a Buy, Before Earnings?
12d ago
MLYS
Mineralys Therapeutics Completes Enrollment for Key Trial
Premium
Company Announcements
Mineralys Therapeutics Completes Enrollment for Key Trial
18d ago
8K
MLYS
Mineralys Therapeutics completes enrollment in Explore-CKD Phase 2 trial
PremiumThe Fly
Mineralys Therapeutics completes enrollment in Explore-CKD Phase 2 trial
18d ago
MLYS
Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
PremiumCompany Announcements
Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
2M ago
8K
MLYS
Mineralys announces Phase 2 trial of lorundrostat in OSA
PremiumThe Fly
Mineralys announces Phase 2 trial of lorundrostat in OSA
2M ago
MLYS
Mineralys Therapeutics Announces Q3 2024 Results and Updates
PremiumCompany Announcements
Mineralys Therapeutics Announces Q3 2024 Results and Updates
3M ago
MLYS
Mineralys Therapeutics reports Q3 EPS ($1.13), consensus (83c)
PremiumThe FlyMineralys Therapeutics reports Q3 EPS ($1.13), consensus (83c)
3M ago
MLYS
Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
4M ago
MLYS
Mineralys Therapeutics Advances Lorundrostat Trial Progress
Premium
Company Announcements
Mineralys Therapeutics Advances Lorundrostat Trial Progress
4M ago
8K
MLYS
Mineralys completes enrollment ahead of schedule in Launch-HTN trial
PremiumThe Fly
Mineralys completes enrollment ahead of schedule in Launch-HTN trial
4M ago
MLYS
Mineralys Therapeutics participates in a conference call with Goldman Sachs
PremiumThe Fly
Mineralys Therapeutics participates in a conference call with Goldman Sachs
4M ago
MLYS
Mineralys Therapeutics to host KOL event on uncontrolled, resistant hypertension
PremiumThe Fly
Mineralys Therapeutics to host KOL event on uncontrolled, resistant hypertension
4M ago
MLYS
Mineralys Therapeutics Hits Enrollment Milestone in Hypertension Trial
PremiumCompany Announcements
Mineralys Therapeutics Hits Enrollment Milestone in Hypertension Trial
5M ago
8K
MLYS
Mineralys Therapeutics completes target enrollment for Advance-HTN Trial
PremiumThe FlyMineralys Therapeutics completes target enrollment for Advance-HTN Trial
5M ago
MLYS
Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)
Premium
The Fly
Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)
6M ago
MLYS
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
7M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >